Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1645-1645
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

How Our Microbiome Influences the Pathogenesis of Alopecia Areata
Pedro Sánchez-Pellicer, Laura Navarro-Moratalla, Eva Núñez-Delegido, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1860-1860
Open Access | Times Cited: 36
Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study
Kona Chowdhury, Mainul Haque, Nadia Nusrat, et al.
Antibiotics (2022) Vol. 11, Iss. 1, pp. 105-105
Open Access | Times Cited: 31
The Role of Cyclodextrins in COVID-19 Therapy—A Literature Review
Beatriz C. Almeida, Cátia Domingues, Filipa Mascarenhas‐Melo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2974-2974
Open Access | Times Cited: 22
Drug safety of frequently used drugs and substances for self-medication in COVID-19
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 24
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 21
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19
Sergio Fazio, Flora Affuso, Paolo Bellavite
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 17
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management
Brit Long, Summer Chavez, Brandon M Carius, et al.
The American Journal of Emergency Medicine (2022) Vol. 56, pp. 158-170
Open Access | Times Cited: 14
Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line
Allison B. Coffin, Emily Dale, Emilee Doppenberg, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry
Yahdiana Harahap, Salsabila Salsabila, Febrina Amelia Saputri
Heliyon (2024) Vol. 10, Iss. 8, pp. e29606-e29606
Open Access | Times Cited: 2
Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial
Irene García-García, Enrique Seco-Meseguer, Pilar Ruíz-Seco, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1139-1139
Open Access | Times Cited: 11
Potential limitations in systematic review studies assessing the effect of the main intervention for treatment/therapy of COVID-19 patients: An overview
Mahsa Mohseni, Hosein Ameri, Morteza Arab‐Zozani
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Guiling Zhou, Stefan Verweij, Maarten J. Bijlsma, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001674-e001674
Open Access | Times Cited: 5
SIT1 transporter as a potential novel target in treatment of COVID-19
Sabina Semiz
BioMolecular Concepts (2021) Vol. 12, Iss. 1, pp. 156-163
Open Access | Times Cited: 11
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
Steven G. Rothrock, Kurt Weber, Philip Giordano, et al.
American Journal of Therapeutics (2021) Vol. 29, Iss. 1, pp. e87-e94
Open Access | Times Cited: 11
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
Nicola Giesen, Elena Busch, Enrico Schalk, et al.
European Journal of Cancer (2022) Vol. 181, pp. 102-118
Open Access | Times Cited: 8
Clinical Characteristics and Outcomes of Patients Hospitalized with COVID-19 at Case Hospital, Uganda
Mirriam Apiyo, Ronald Olum, Amina Kabuye, et al.
Interdisciplinary Perspectives on Infectious Diseases (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 7
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
Manuel Castillejos‐López, Luz María Torres‐Espíndola, Juan Carlos Huerta­-Cruz, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1384-1384
Open Access | Times Cited: 7
Political Prescriptions: Three Pandemic Stories
Nishtha Bharti, Sergio Sismondo
Science Technology & Human Values (2022) Vol. 49, Iss. 2, pp. 371-402
Closed Access | Times Cited: 7
Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 infection among healthcare workers: a prospective cohort study
Akshay Rao, Sundar Kumar Veluswamy, Banashankari Gunjiganur Shankarappa, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 5, pp. 781-787
Open Access | Times Cited: 4
Unvaccinated COVID-19 Pneumonia- a family affair
Trilok Stead, Michael Hughes, Frank Fraunfelter, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 3
Implementation and Outcomes of an Empiric Ivermectin Strongyloides Treatment Protocol for Patients Receiving High-Dose Corticosteroids for Severe COVID-19
Benjamin Swart, Aileen Ahiskali, Jack M. Wolf, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 3, pp. 650-655
Open Access | Times Cited: 1
Clinical Experience With Ivermectin and Nitazoxanide in the Management of COVID-19 Among Mexican Out- and Inpatients
Jorge García-Méndez, Luis E. Fernández-Garza, Karen Vallejo-Oviedo, et al.
Cureus (2024)
Open Access
Correction: Cruciani et al. Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis. Diagnostics 2021, 11, 1645
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2359-2359
Open Access | Times Cited: 3
Alteração do perfil de pacientes internados por COVID-19 no Vale do Paranhana - RS
Lucimara Prates da Silva, Gabriela de Carvalho Muniz, Joice Adriana da Silva, et al.
Revista Eletrônica Acervo Saúde (2022) Vol. 15, Iss. 4, pp. e9769-e9769
Open Access | Times Cited: 2
Estudo infodemiológico das tendências de buscas relacionadas à COVID-19 no Brasil
Thalita Zago Oliveira, João Paulo Alves Cunha, Vinícius Detoni Lopes, et al.
Research Society and Development (2022) Vol. 11, Iss. 7, pp. e14211729581-e14211729581
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top